Home Healthcare Plans: Amedisys (NASDAQ:AMED), Chemed Corporation (NYSE:CHE), BioScrip (NASDAQ:BIOS), Gentiva Health Services (NASDAQ:GTIV)

Amedisys Inc. (NASDAQ:AMED), one of the nation’s largest home health providers, will pay $150 million to settle claims that it exaggerated Medicare billings and had improper financial relations with referring physicians, the Department of Justice revealed. Amedisys Inc (NASDAQ:AMED) shares after opening at $13.75 moved to $13.95 on last trade day and at the end of the day closed at $13.75. Company price to sales ratio in past twelve months was calculated as 0.36 and price to cash ratio as 26.01. Amedisys Inc (NASDAQ:AMED) showed a negative weekly performance of -0.22%.

Chemed Corporation (NYSE:CHE) was downgraded by analysts at Zacks from an outperform rating to a neutral rating. Chemed Corporation (NYSE:CHE) shares fell -1.93% in last trading session and ended the day on $85.97. Chemed Corporation (NYSE:CHE) return on equity ratio is recorded as 16.80% and its return on assets is 8.60%. Chemed Corporation (NYSE:CHE) yearly performance is 22.34%.

Beaten down small cap home care and infusion stock BioScrip Inc (NASDAQ: BIOS) was recently called a potential takeover target, meaning its worth taking a closer look at the stock along with healthcare ETFs like the iShares Dow Jones US Health Care ETF (NYSEARCA: IHF) or the Late last February, BioScrip fell as much as 13% after the reporting fourth quarter earnings that exceeded top line expectations but also missed at the bottom line. Health Care SPDR ETF (NYSEARCA: XLV). BioScrip Inc (NASDAQ:BIOS) shares moved down -2.99% in last trading session and was closed at $7.14, while trading in range of $7.07 – $7.37. BioScrip Inc (NASDAQ:BIOS) year to date (YTD) performance is -3.51%.

Gentiva Health Services, Inc. (NASDAQ:GTIV) announced that it has scheduled a conference call and webcast on Wednesday, May 7, 2014, at10:00 a.m. ET to discuss operating results for the first quarter ended March 31, 2014. Gentiva Health Services, Inc. (NASDAQ:GTIV) plans to issue its financial news release the morning of May 7, 2014 before pre-market trading. Gentiva Health Services, Inc. (NASDAQ:GTIV) weekly performance is 2.20%. On last trading day company shares ended up $7.89. Gentiva Health Services, Inc. (NASDAQ:GTIV) distance from 50-day simple moving average (SMA50) is -14.21%. Analysts mean target price for the company is $9.86.